MedTrace Logo

Markers for Predicting Risk of Breast Cancer in Women of Different Races

NCT02574546 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-02-25

No results posted yet for this study

Summary

This research is being done to learn more about the risk of developing breast cancer by studying cells from both normal breast tissue and breast cancer tumor tissue. The goal is to study cells, genes, and gene products to help us to learn how to detect cancer in its earliest stages, and if this information may differ in patients with different ethnic backgrounds.

Conditions

Interventions

PROCEDURE

Mastectomy

Unilateral breast cancers planning bilateral mastectomy procedures.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Saraswati Sukumar, Ph.D. · SKCCC at Johns Hopkins

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-01-31
Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02574546 on ClinicalTrials.gov